TNGN has the most promise for any regenerative medicine stock trading right now. TNGN could surely be an $18 to $50 stock someday. The upside is tremendous for TNGN.
Think about adding now, because TNGN is a $20 Nasdaq biotech, that is trading for pennies.
Think these are just regular investors buying right now? I bet not, most likely those who know what TNGN has in store for the future.
Did I miss the PR that indicated TNGN has revenues???? Or is the stock run the work of the BOD so it stays listed. When a stock heads to the pinks it is very difficult to get funding. From what I have seen since the IPO these guys are only worried about one (1) thing - Paychecks. No funding - No Paychecks.